Catalent Marks 40 Years in Japan with New Investments and Country Leader
Catalent appoints a new country leader and expands facilities.
Catalent now in its 40th year of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products in the Japanese market and has appointed Tadahiro Matsumura as Country Leader. Based in Catalent’s Tokyo office, Matsumura will be responsible for driving growth through business development activities in Japan and the surrounding region.
In addition, the company has opened a laboratory at its Kakegawa, Japan site to provide proof-of-concept support and feasibility studies for Catalent’s Zydis Orally Dispersible Tablet (ODT) technology and will also expand manufacturing capacity for its OptiGel Micro softgel technology. Zydis ODT is a freeze-dried oral dosage form that disperses in the mouth, requiring no water. The new Zydis laboratories, which will be officially opened as part of the 40th anniversary celebrations in September, is being constructed within the existing 107,000 square-foot Kakegawa facility. Catalent’s OptiGel Micro Technology uses a droplet, streamline flow that results in spherical capsules. These capsules can be sized from 1-7mm, which allows for smaller capsules to be produced when compared to the traditional rotary die process.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
